Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ACITRETIN

02 1ACYCLOVIR

03 1ALLEGRA

04 1ALLEGRA ALLERGY

05 1ALLEGRA HIVES

06 2APREPITANT

07 3CHILDRENS ALLEGRA ALLERGY

08 3CHILDRENS ALLEGRA HIVES

09 1CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY

10 1CHILDRENS FEXOFENADINE HYDROCHLORIDE HIVES

11 1CINACALCET HYDROCHLORIDE

12 1DEFERASIROX

13 1DULOXETINE HYDROCHLORIDE

14 1EXELDERM

15 1FAMCICLOVIR

16 1FENOFIBRATE

17 10GABAPENTIN

18 1ISENTRESS

19 1ISENTRESS HD

20 1LOTEMAX SM

21 1METHADOSE

22 1OMEPRAZOLE

23 1OTIPRIO

24 2RALOXIFENE HYDROCHLORIDE

25 1RELGAABI

26 1REPAGLINIDE

27 2SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

28 1ZMAX

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

GABAPENTIN

Drug : GABAPENTIN

Dosage Form : TABLET; ORAL

Application Number : 203244

Country : US

Patented : No

Strides Pharma Science

02

PEGS Boston Summit
Not Confirmed
arrow

03

PEGS Boston Summit
Not Confirmed
arrow

04

PEGS Boston Summit
Not Confirmed
arrow

05

PEGS Boston Summit
Not Confirmed
arrow

06

PEGS Boston Summit
Not Confirmed
arrow

07

PEGS Boston Summit
Not Confirmed
arrow

08

PHARMOBEDIENT

Gabapentin

PEGS Boston Summit
Not Confirmed
arrow
PHARMOBEDIENT
arrow
PEGS Boston Summit
Not Confirmed

GABAPENTIN

Drug : GABAPENTIN

Dosage Form : TABLET; ORAL

Application Number : 90335

Country : US

Patented : No

blank

09

SCIEGEN PHARMS

Gabapentin

PEGS Boston Summit
Not Confirmed
arrow
SCIEGEN PHARMS
arrow
PEGS Boston Summit
Not Confirmed

GABAPENTIN

Drug : RELGAABI

Dosage Form : CAPSULE; ORAL

Application Number : 204989

Country : US

Patented : No

blank

10

SCIEGEN PHARMS

Gabapentin

PEGS Boston Summit
Not Confirmed
arrow
SCIEGEN PHARMS
arrow
PEGS Boston Summit
Not Confirmed

GABAPENTIN

Drug : GABAPENTIN

Dosage Form : TABLET; ORAL

Application Number : 205101

Country : US

Patented : No

blank